Search

Displaying results 5561 - 5570 of 7687 in total
  1. Drug

    VGB-R04

    go.drugbank.com/drugs/DB18615
    Investigational

    VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.

  2. Drug

    Zedenoleucel

    go.drugbank.com/drugs/DB18639
    Investigational

    MT-401 is an allogeneic multi-tumor-associated antigen-specific T-cell therapy.

  3. Drug

    ABBV-706

    go.drugbank.com/drugs/DB18710
    Investigational

    ABBV-706 is an antibody-drug conjugate that is anti-SEZ6.[L49156,L49161]

  4. Drug

    Lixudebart

    go.drugbank.com/drugs/DB19244
    Investigational

    Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.[L50833]

  5. Drug

    H-151

    go.drugbank.com/drugs/DB29149
    Experimental

    H-151 is an inhibitor of the stimulator of interferon genes (STING) protein.

  6. Drug

    CYP-001

    go.drugbank.com/drugs/DB15739
    Investigational

    The MCA-derived MSCs can be obtained from induced pluripotent stem cells (iPSCs) and then expanded in media. … These cells have advantage over other MSCs because a large amount can be obtained from a single healthy blood donor, negating the risks from donor-and expansion dependent variability.

  7. Drug

    Mebenil

    go.drugbank.com/drugs/DB14728
    Experimental

    An obsolete fungicide used to control various pathogens on cereals and seed potatoes.

  8. Drug

    Neltenexine

    go.drugbank.com/drugs/DB13239
    Investigational

    Neltenexine is an elastase inhibitor. It may be useful for preventing pulmonary emphysema.

  9. Drug

    Phenylmercuric acetate

    go.drugbank.com/drugs/DB17044
    Experimental

    Phenylmercuric acetate is an organomercurial compound used as a fungicide and slimicide.[A253082]

  10. Drug

    VO659

    go.drugbank.com/drugs/DB18160
    Investigational

    VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.

    Synonyms: an antisense oligonucleotide that has been developed to target expanded CAG repeats in messenger ribonucleic acid (mRNA)